PT MSIG Life Insurance Indonesia Tbk (IDX:LIFE)
Indonesia · Delayed Price · Currency is IDR 7,525.00
-25.00 (-0.33%)
Apr 21, 2026, 3:47 PM WIB
IDX:LIFE Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 2,170,577 | 1,968,826 | 1,554,247 | 2,569,686 | 2,575,197 | 3,596,923 |
Total Interest & Dividend Income | 216,855 | 200,019 | 460,360 | 730,589 | 614,382 | 581,843 |
Gain (Loss) on Sale of Investments | 437,207 | 437,207 | 21,262 | 98,164 | 107,929 | -187,337 |
Other Revenue | 3,749 | - | - | 39,034 | 136,771 | 47,243 |
| 2,869,459 | 2,647,016 | 2,076,871 | 3,494,268 | 3,457,500 | 4,073,408 | |
Revenue Growth (YoY) | -20.41% | 27.45% | -40.56% | 1.06% | -15.12% | -6.58% |
Policy Benefits | 1,257,987 | 1,196,120 | 763,294 | 1,956,316 | 2,154,156 | 3,124,914 |
Policy Acquisition & Underwriting Costs | 640,610 | 667,017 | 618,106 | 729,924 | 463,171 | 383,543 |
Selling, General & Administrative | 297,481 | 286,307 | 180,728 | 494,861 | 416,129 | 388,925 |
Other Operating Expenses | 222,912 | 265,191 | 220,621 | 16,903 | 17,522 | 48,226 |
Total Operating Expenses | 2,412,291 | 2,414,635 | 1,782,749 | 3,198,004 | 3,050,978 | 3,945,608 |
Operating Income | 457,168 | 232,381 | 294,122 | 296,264 | 406,522 | 127,800 |
Currency Exchange Gain (Loss) | - | - | - | -11,011 | 49,990 | 2,012 |
Other Non Operating Income (Expenses) | 66,567 | 66,567 | 40,048 | - | - | - |
EBT Excluding Unusual Items | 523,735 | 298,948 | 334,170 | 285,253 | 456,512 | 129,812 |
Merger & Restructuring Charges | -8,498 | -8,498 | -16,238 | - | - | - |
Gain (Loss) on Sale of Assets | 1,690 | 1,690 | 1,534 | 1,669 | 3,078 | 4,889 |
Asset Writedown | -10,533 | -10,533 | -5,177 | 2,189 | 7,219 | 4,524 |
Legal Settlements | - | - | 128,148 | -90,000 | -38,148 | - |
Pretax Income | 506,394 | 281,607 | 442,437 | 199,111 | 428,661 | 139,225 |
Income Tax Expense | 75,790 | 75,379 | 70,748 | 72,623 | 60,888 | 65,401 |
Net Income | 430,604 | 206,228 | 371,689 | 126,488 | 367,773 | 73,824 |
Net Income to Common | 430,604 | 206,228 | 371,689 | 126,488 | 367,773 | 73,824 |
Net Income Growth | 55.48% | -44.52% | 193.85% | -65.61% | 398.18% | -77.69% |
Shares Outstanding (Basic) | 2,100 | 2,100 | 2,100 | 2,100 | 2,100 | 2,100 |
Shares Outstanding (Diluted) | 2,100 | 2,100 | 2,100 | 2,100 | 2,100 | 2,100 |
EPS (Basic) | 205.05 | 98.20 | 176.99 | 60.23 | 175.13 | 35.15 |
EPS (Diluted) | 204.85 | 98.00 | 176.99 | 60.00 | 175.13 | 35.00 |
EPS Growth | 55.76% | -44.63% | 194.99% | -65.74% | 400.37% | -77.79% |
Free Cash Flow | - | 510,068 | -609,781 | -877,184 | -1,327,051 | 883,362 |
Free Cash Flow Per Share | - | 242.89 | -290.37 | -417.71 | -631.93 | 420.65 |
Dividend Per Share | - | - | 160.000 | 38.000 | 177.000 | 34.000 |
Dividend Growth | - | - | 321.05% | -78.53% | 420.59% | -86.01% |
Operating Margin | 15.93% | 8.78% | 14.16% | 8.48% | 11.76% | 3.14% |
Profit Margin | 15.01% | 7.79% | 17.90% | 3.62% | 10.64% | 1.81% |
Free Cash Flow Margin | - | 19.27% | -29.36% | -25.10% | -38.38% | 21.69% |
EBITDA | 475,407 | 249,459 | 309,054 | 318,760 | 426,744 | 151,552 |
EBITDA Margin | 16.57% | 9.42% | 14.88% | 9.12% | 12.34% | 3.72% |
D&A For EBITDA | 18,239 | 17,078 | 14,932 | 22,496 | 20,222 | 23,752 |
EBIT | 457,168 | 232,381 | 294,122 | 296,264 | 406,522 | 127,800 |
EBIT Margin | 15.93% | 8.78% | 14.16% | 8.48% | 11.76% | 3.14% |
Effective Tax Rate | 14.97% | 26.77% | 15.99% | 36.47% | 14.20% | 46.98% |
Revenue as Reported | 222,443 | - | - | 3,495,887 | 3,521,147 | 4,091,250 |
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.